Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalised medicine in asthma: time for action: Number 1 in the Series "Personalised medicine in respiratory diseases" Edited by Renaud Louis and Nicolas Roche.

European respiratory review : an official journal of the European Respiratory Society - 30 Sept 2017

Chung Kian Fan

Abstract excerpt

Asthma is a heterogeneous disease comprising several phenotypes driven by different pathways. To define these phenotypes or endotypes (phenotypes defined by mechanisms), an unbiased approach to clustering of various omics platforms will yield molecular phenotypes from which composite biomarkers can be obtained. Biomarkers can help differentiate between these phenotypes and pinpoint patients suitable for specific...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Asthmatic Agents
Share to Asthma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Clinical Decision-Making

Share to Molecular Diagnostic Techniques

Share to Patient Selection

Share to Precision Medicine

Share to Predictive Value of Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 28954768
DOI: 10.1183/16000617.0064-2017
PMCID: PMC9488697

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalised medicine in asthma: time for action: Number 1 in the Series "Personalised medicine in respiratory diseases" Edited by Renaud Louis and Nicolas Roche.PMID 28954768Read ↗

Personalised medicine in asthma: from curative to preventive medicine.Semantic proximity Read ↗

Personalised medicine in interstitial lung diseases: Number 6 in the Series "Personalised medicine in respiratory diseases" Edited by Renaud Louis and Nicolas Roche.Semantic proximity Read ↗

Towards precision medicine: The application of omics technologies in asthma managementSemantic proximity Read ↗

Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits.Semantic proximity Read ↗

Precision medicine in airway diseases: moving to clinical practice.Semantic proximity Read ↗

[UNDERSTANDINGS OF ASTHMA PHENOTYPES, GENOTYPES AND ENDOTYPES TOWARDS PRECISION MEDICINE].Semantic proximity Read ↗

Asthma: personalized and precision medicine.Semantic proximity Read ↗

Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for "Omics" Technology?Semantic proximity Read ↗

Treatable traits: toward precision medicine of chronic airway diseases.Semantic proximity Read ↗

Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?Semantic proximity Read ↗

What did we learn from multiple omics studies in asthma?Semantic proximity Read ↗

Asthma genetics and personalised medicine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.